ClinicalTrials.Veeva

Menu

Chicago Community Health Study (CCHS)

The University of Chicago logo

The University of Chicago

Status

Completed

Conditions

Smoking

Treatments

Behavioral: Enhanced Care
Behavioral: TAU

Study type

Interventional

Funder types

Other

Identifiers

NCT04460417
IRB16-1573

Details and patient eligibility

About

The study examined smokers from the initial COMPASS survey who live in one of three local Census tracks with large concentrations of minority populations and smoking rates, including Washington Park (98.8% African American, 60.5% smoker), Gage Park (76.7% Hispanic, 26.7% smoker), and Bridgeport (34.5% Asian, 27.0% Hispanic, 29.3% smoker), randomizing them to receipt of treatment as usual care advice (via a pamphlet form the National Cancer Institute) versus theoretically-driven and empirically-supported smoking cessation advice session delivered in-person at the UCM.

Enrollment

204 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Currently reside in either the Washington Park, Gage Park, or Bridgeport communities based on current physical address at the time of initial contact for study participation
  • Identify as a current smoker (verified by self-report and exhaled carbon monoxide)
  • Willing and able to sign an informed consent
  • Stable residence and contact information throughout the follow-up period

Exclusion criteria

  • Not a current smoker
  • Does not live within the pre-determined neighborhood locations
  • Unable to sign informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

204 participants in 2 patient groups

Enhanced care
Experimental group
Description:
Participants will take part in an approximate one-hour health and smoking feedback session at the University of Chicago in Dr. King's Clinical Addictions Research Laboratory (CARL). The session will follow the Courage to Quit™ (CTQ) Roadmap program (developed by Dr. King with the Respiratory Health Association). This roadmap shorter version of the larger CTQ program has been specifically designed as an inpatient bedside or outpatient brief intervention guide to assess smoking cessation motivation, consequences of smoking, facts and myths about smoking, barriers to making a change, approved medications, de-bunking myths about medications or treatments without scientific evidence (e-cigarette, laser treatments, herbals, etc.), and gaining social support.
Treatment:
Behavioral: Enhanced Care
Treatment as Usual
Active Comparator group
Description:
Participants will receive the National Cancer Institute (NCI) pamphlet "Clearing the Air" and access to related online resources, which includes brief advice to quit smoking and medication information.
Treatment:
Behavioral: TAU

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems